Cargando…
Assessment of the relationship of basal serum anti-mullerian hormone levels with oocyte quality and pregnancy outcomes in patients undergoing ICSI
BACKGROUND: Anti-Mullerian hormone (AMH) is constantly secreted during menstrual cycles and may offer several advantages over traditional biomarkers of ovarian reserve. OBJECTIVE: To assess the relationship of anti-Mullerian hormone (AMH) values, which are used to evaluate ovary reserves, with oocyt...
Autores principales: | Aydın, Gültekin Adanaş, Yavuz, Arzu, Terzi, Hasan, Kutlu, Tayfun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Research and Clinical Center for Infertility
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4475773/ https://www.ncbi.nlm.nih.gov/pubmed/26131013 |
Ejemplares similares
-
Anti-mullerian and androgens hormones in women with polycystic ovary syndrome undergoing IVF/ICSI
por: Swellam, Menha, et al.
Publicado: (2013) -
Anti-Müllerian Hormone and OPU-ICSI Outcome in the Mare
por: Papas, Marion, et al.
Publicado: (2021) -
Association between serum estradiol level on the hCG administration day and IVF-ICSI outcome
por: Kara, Mustafa, et al.
Publicado: (2012) -
Prediction of metaphase II oocytes according to different serum
Anti-Müllerian hormone (AMH) levels in antagonist ICSI
cycles
por: da Silva, Joyce B, et al.
Publicado: (2016) -
High anti-Müllerian hormone levels might not reflect the likelihood of clinical pregnancy rate in IVF/ICSI treatment
por: Sun, Tie-Cheng, et al.
Publicado: (2021)